The Keystone Program in Personalized Kidney Cancer Therapy

The Potential

“This program could easily achieve ‘Top 5’ status. Most other kidney cancer programs in the country either lack this scientific depth and/or lack sufficient clinical expertise.” – Keystone Programs External Review Panel

The Keystone Program in Personalized Kidney Cancer Therapy will:

• Hunt for new molecules and molecular pathways that could serve as targets for future therapeutics.
• Uncover the molecular mechanisms that promote resistance to current therapies.
• Use the characteristics of an individual tumor to personalize kidney cancer therapy.
• Leverage the existing expertise at Fox Chase to create a world-class model program for organ-site cancer research and care.